Trial intelligence / Profile preview

Propofol vs Sevoflurane in DIEP Flap Breast Reconstruction

NCT05136508Completed

Sponsor
Yonsei University
Start
May 2021
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of propofol injection (veterinary) in breast cancer (2 arms), sponsored by Yonsei University. Primary endpoint: Blood concentration of syndecan-1. Started May 2021; status: completed.

02

Drugs

propofol injection (veterinary)
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT05136508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05136508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call